StockData
SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc. (SABS) stock

SABSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$2.95−0.05 (-1.67%)

Close on Nov 17, 2026Market cap $268.41MP/E –Yield –

SAB Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

SAB Biotherapeutics's market cap was $259.66M on Nov 11, 2026, against $187.60M a year earlier. Over the last 5 years it ranged from $12.63M to $380.64M, with a median of $55.40M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$259.66M+46.2%
2025Dec 31, 2025$177.63M+407.3%
2024Dec 31, 2024$35.02M-44.8%
2023Dec 29, 2023$63.48M+41.7%
2022Dec 30, 2022$44.80M-1.3%
2021Dec 31, 2021$45.37M–

More SAB Biotherapeutics figures

See a number that looks wrong?